Stable inhibition of hTERT gene by siRNA in hepatocarcinoma cells
Peng Zhang
Abstract
Peng Zhang
Abstract
AIM: To elucidate the time-efficiency relation of stable inhibition of hepatocarcinoma cell proliferation by RNA interference in vitro. METHODS: The stable screening-inhibition technique of RNAi was adopted to suppress the expression of hTERT stably. After small hairpin RNA (shRNA) targeting hTERT gene was designed, recombinant vector pGenesil-shRNA-hTERT was constructed and transfected into hepatocarcinoma SMMC-7721 cells, which were stably selected by G418 to establish hepatocarcinoma cell lines stablely expressing pGenesil-shRNA-hTERT. Real-time RT-PCR, MTT and PCR-TRAP were utilized to detect the alterations of hTERT mRNA expressions, telomerase activity and cell proliferation. RESULTS: The effectiveness of RNAi existed continually and stably in hepatocarcinoma SMMC-7721 cells expressing stably pGenesil-shRNA-hTERT. In the cell lines expressing stably pGenesil-shRNA-hTERT, hTERT mRNA was obviously suppressed, and the telomerase activities were significantly decreased. Hepatocarcinoma SMMC-7721 cell proliferation significantly inhibited in pGenesil-shRNA-hTERT group compared to that in negative control group. CONCLUSION: RNAi may continually and stably suppress hTERT mRNA expression and carcinoma cell proliferation, which is a potential new approach for anti-tumor gene therapy.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To elucidate the time-efficiency relation of stable inhibition of hepatocarcinoma cell proliferation by RNA interference in vitro. METHODS: The stable screening-inhibition technique of RNAi was adopted to suppress the expression of hTERT stably. After small hairpin RNA (shRNA) targeting hTERT gene was designed, recombinant vector pGenesil-shRNA-hTERT was constructed and transfected into hepatocarcinoma SMMC-7721 cells, which were stably selected by G418 to establish hepatocarcinoma cell lines stablely expressing pGenesil-shRNA-hTERT. Real-time RT-PCR, MTT and PCR-TRAP were utilized to detect the alterations of hTERT mRNA expressions, telomerase activity and cell proliferation. RESULTS: The effectiveness of RNAi existed continually and stably in hepatocarcinoma SMMC-7721 cells expressing stably pGenesil-shRNA-hTERT. In the cell lines expressing stably pGenesil-shRNA-hTERT, hTERT mRNA was obviously suppressed, and the telomerase activities were significantly decreased. Hepatocarcinoma SMMC-7721 cell proliferation significantly inhibited in pGenesil-shRNA-hTERT group compared to that in negative control group. CONCLUSION: RNAi may continually and stably suppress hTERT mRNA expression and carcinoma cell proliferation, which is a potential new approach for anti-tumor gene therapy.
Key concepts: Telomerase reverse transcriptase, Small hairpin RNA, RNA interference, Telomerase, Transfection, Molecular biology, Biology, Cell growth